Although maximum levels of IgG-S1, in both serum and milk, were observed 2 weeks after the second dose of vaccine with a subsequently progressive parallel decrease, we found an increase in antibody levels in 6-month follow-up samples in 2 participants related to a previous infection by SARS-CoV-2. Here, PSMD1 is linked to infection.